
FDA Accepts NDA for Tonix’s Sleep-Improving Drug for Fibromyalgia
Summary: Tonix Pharmaceuticals has announced that the FDA has accepted the New Drug Application (NDA) for TNX-102 SL, a non-opioid treatment for fibromyalgia. The NDA is supported by clinical trial data showing that TNX-102 SL improves pain relief and sleep quality, among other key endpoints. The drug has already received Fast Track designation from the…